Rchr
J-GLOBAL ID：200901065481076482   Update date: Nov. 01, 2024

Saito Kyoko

Saito Kyoko | Saito Kyoko
Affiliation and department：
National Institute of Infectious Diseases

About National Institute of Infectious Diseases


Research field  (3)： Virology ,  Pharmacology ,  Pharmaceuticals - health and biochemistry
Research keywords  (5)： 脂質生化学 ,  ウイルス学 ,  遺伝学 ,  細胞生物学 ,  生化学
Research theme for competitive and other funds  (15)：
  • 2021 - 2025 Construction of a new Vero cell system to be the basis for coronavirus research and vaccine development
  • 2021 - 2025 A replicon-based screen of yellow fever virus host factors: Toward generation of highly productive virus-producer cell lines
  • 2020 - 2022 改良型ウイルス増殖細胞の創出と細胞基材の安全性強化に向けて
  • 2017 - 2021 Construction of improved virus-susceptible host cells by genome editing
  • 2016 - 2020 フラビウイルスが必要とする宿主脂質に関する研究
Show all
Papers (31)：
  • Kentaro Shimasaki, Yuko Okemoto-Nakamura, Kyoko Saito, Masayoshi Fukasawa, Kaoru Katoh, Kentaro Hanada. Deep learning-based segmentation of subcellular organelles in high-resolution phase-contrast images. Cell structure and function. 2024. 49. 2. 57-65
  • Approval review of biological products. PHARM TECH JAPAN. 2024. 40. 5. 73-76
  • Kentaro Shimasaki, Yuko Okemoto-Nakamura, Kyoko Saito, Masayoshi Fukasawa, Kaoru Katoh, Kentaro Hanada. A high-resolution phase-contrast microscopy system for label-free imaging in living cells. Cell Structure and Function. 2024. 49. 1. 21-29
  • Kyoko Saito, Kentaro Shimasaki, Masayoshi Fukasawa, Ryosuke Suzuki, Yuko Okemoto-Nakamura, Kaoru Katoh, Tomohiko Takasaki, Kentaro Hanada. Establishment of Vero cell lines persistently harboring a yellow fever virus 17D subgenomic replicon. Virus research. 2022. 322. 198935-198935
  • Yamanaka A, Matsuda M, Okabayashi T, Pitaksajjakul P, Ramasoota P, Saito K, Fukasawa M, Hanada K, Matsuura T, Muramatsu M, et al. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012. mSphere. 2021. 6. 4. e0033921-12
ｍore...
MISC (13)：
ｍore...
Books (1)：
  • グッドマンギルマン薬理書第13版
    廣川書店 2022
Lectures and oral presentations  (39)：
  • Lessons from Our Experiences in Pre Approval Testing and Summary Lot Protocol Review of mRNA Vaccines in Japan
    (2024 APEC Communication Platform for Analytical Technology of mRNA Derived Medicinal Products Workshop 2024)
  • 培養細胞におけるC型肝炎ウイルスの増殖に対する発酵大豆由来成分の効果
    (日本薬学会第144年会)
  • ウイルス高感受性Vero細胞株樹立の試み STAT1を欠損させたポリオウイルス非感受性Vero細胞の樹立
    (日本薬学会第144年会)
  • 副反応評価マウスモデルによる低反応原性mRNA脂質ナノ粒子ワクチンのスクリーニング
    (第27回日本ワクチン学会・第64回日本臨床ウイルス学会合同学術集会)
  • 日本脳炎ウイルス持続感染細胞株の樹立とその持続感染メカニズムの解析
    (第70回日本ウイルス学会学術集会)
ｍore...
Education (2)：
  • 1989 - 1991 University of Tokyo Graduate School of Pharmaceutical Sciences (Master's course)
  • 1985 - 1989 University of Tokyo Faculty of Pharmaceutical Sciences
Professional career (1)：
  • 博士(薬学) (東京大学)
Work history (3)：
  • 2023/04 - 現在 National Institute of Infectious Diseases Laboratory of Cell Function, Department of Biochemistry and Cell Biology Chief
  • 2007/04 - 2023/03 National Institute of Infectious Diseases Department of Biochemistry and Cell Biology Senior Research Scientist
  • 1991/04 - 2007/03 National Institute of Infectious Diseases Department of Biochemistry and Cell Biology Research Scientist
Committee career (2)：
  • 2024/03 - 現在 独立行政法人医薬品医療機器総合機構専門員
  • 2023/04 - 現在 公益社団法人日本薬学会 ファルマシア委員
Association Membership(s) (4)：
THE JAPANESE SOCIETY FOR VIROLOGY ,  THE JAPANESE CONFERENCE ON THE BIOCHEMISTRY OF LIPIDS ,  THE PHARMACEUTICAL SOCIETY OF JAPAN ,  THE JAPANESE BIOCHEMICAL SOCIETY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM